Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy

Sunita Keshari, Alexander S. Shavkunov, Qi Miao, Akata Saha, Tomoyuki Minowa, Martina Molgora, Charmelle D. Williams, Mehdi Chaib, Anna M. Highsmith, Josué E. Pineda, Sayan Alekseev, Elise Alspach, Kenneth H. Hu, Marco Colonna, Kristen E. Pauken, Ken Chen, Matthew M. Gubin